How Much Does Mounjaro Cost?

As of October 8, 2026, Mounjaro’s list price is $1,112.16 per 28-day fill at every dose (Lilly pricing). Without insurance, Costco members pay $1,103.95 and GoodRx shows coupons from $1,087.18, location not shown. Lilly publishes no Mounjaro self-pay price; its savings card brings a covered fill to $25 (Mounjaro savings).

How much does Mounjaro cost without insurance?

Quick answer: About $1,103.95 to $1,112.16 per 28-day fill of four pens, at any dose, as of October 8, 2026. Lilly lists no self-pay price.

Mounjaro comes as a box of four single-dose pens, one per week, and Lilly defines a fill as 28 days. Unlike Zepbound, the price does not change with the dose.

Mounjaro without insurance	Price	Conditions	Source
List price	$1,112.16	Per 28-day fill, every dose; wholesale list price, not what insured patients pay	Lilly pricing
Costco member price	$1,103.95	Per 4 pens at pickup; delivery costs slightly more	Costco price search
GoodRx coupon, as low as	$1,087.18	Per 4 pens; GoodRx does not show a pharmacy or location	GoodRx
GoodRx average retail price	$1,348.35	Most common version, without a coupon	GoodRx
LillyDirect self-pay	No price published	Lilly says only that self-pay options may exist	Lilly pricing

All figures checked October 8, 2026. TrumpRx.gov lists Mounjaro at $499 with “eligibility required” but does not say who qualifies; Lilly’s only published $499 Mounjaro price is its card for commercial plans that do not cover Mounjaro (TrumpRx).

How much does Mounjaro cost with insurance?

Quick answer: With commercial coverage, as little as $25 a fill with Lilly’s savings card; if your commercial plan doesn’t cover Mounjaro, as low as $499.

Mounjaro savings card	You pay	Conditions	Source
Commercial plan covers Mounjaro	$25	As little as, per 1-, 2- or 3-month fill; savings capped at $150 per 1-month fill and $1,950 a year	Mounjaro savings
Commercial plan does not cover Mounjaro	$499	As low as, per 28-day fill of up to 4 pens; savings capped at $647 a month	Mounjaro savings

Both cards expire December 31, 2026, allow up to 13 fills a year, and exclude people with Medicare, Medicaid or other government coverage. Checked October 8, 2026.

Coverage depends on the drug, diagnosis, plan formulary and prior authorization. Ask about the cost after your deductible and any required clinical documentation. Commercial savings and self-pay offers have different rules. Medicare GLP-1 Bridge is a temporary program for certain eligible beneficiaries beginning in July 2026; it does not mean automatic coverage for everyone. CMS: Medicare GLP-1 Bridge eligibility

Does Zepbound’s self-pay price apply to Mounjaro?

Quick answer: No. Zepbound’s LillyDirect prices start at $299 a month, but they don’t establish a Mounjaro price; the two have different programs and approved uses.

Mounjaro is indicated for type 2 diabetes; Zepbound has its own indications including weight management. Zepbound self-pay offers advertise a starting price of $299 for a four-week supply of 2.5 mg in a KwikPen or vials; this is a starting dose, not maintenance. Later costs depend on dose, device and refill terms. That offer does not establish a Mounjaro price. Check each manufacturer’s information, reviewed October 8, 2026. Source: Zepbound manufacturer savings terms Source: Mounjaro manufacturer cost information

What do REMEVi plans cost, and how are they billed?

Quick answer: REMEVi bills every four weeks, not by calendar month, and the 12- and 24-week plans are paid upfront. These are compounded preparations, not Mounjaro.

REMEVi prices use four-week billing periods, which are not calendar months. The 12- and 24-week terms require the full total upfront. Lab work that the clinician requires for treatment is included.

Compounded preparation	Every 4 weeks	12 weeks: total upfront	24 weeks: total upfront
Injectable semaglutide	$199	$507 ($169/4 weeks)	$954 ($159/4 weeks)
Injectable tirzepatide	$269	$699 ($233/4 weeks)	$1,350 ($225/4 weeks)
Compounded oral semaglutide	$249	$687 ($229/4 weeks)	$1,290 ($215/4 weeks)

See current semaglutide and tirzepatide plan details. Compounded oral semaglutide is not an approved Wegovy, Ozempic or Rybelsus tablet. Eligibility and prescribing depend on clinical evaluation. Service is available in 49 states and Washington, DC, excluding Louisiana.

Is compounded tirzepatide FDA-approved?

Quick answer: No. Compounded preparations are not FDA-approved, are not generics of Mounjaro or any brand, and have no established clinical equivalence to them.

Compounded preparations are not FDA-approved, are not generics of the brands and do not have established clinical equivalence to them. FDA recommends their use only when an available approved product cannot meet the medical need. A lower price does not establish equal safety or effectiveness. Source: FDA: unapproved GLP-1 medicines

What should I check before choosing?

Quick answer: The product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy — and who handles side effects.

Confirm the product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy. Ask who handles side effects and what happens if clinical review does not recommend treatment. Review care options.